Healthcare ❯Pharmaceuticals

Weight Loss Drugs

Weight Loss Drugs Pharmaceuticals Drug Development Market Analysis Weight Loss Treatments Stock Market Pharmaceutical Industry Company Performance Pharmaceuticals Drug Efficacy

Novo Nordisk CEO Steps Down Following Share Price Collapse

Lars Fruergaard Jørgensen will remain temporarily to ensure a smooth transition as the company faces intensified competition and market pressures.

UK Nears One Million Users of Weight-Loss Jabs as New Benefits and Risks Emerge

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Hims & Hers Expands Weight-Loss Offerings with New Medications

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Poll Shows Americans Divided Over Weight-Loss Drugs for Obesity Treatment